YNYing Nie

Ying Nie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ying Nie has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of κ ‐Carrageenan on the Textural, Microstructural, and Molecular Properties of Heat‐Induced Egg White Protein Gel

    by Yuping Wei, Shaomin Lin, Weicong Lin, Ying Nie, Xianghui Zou, Yuzhong Zheng, Biansheng Li, Yuwei He, Yisheng Huang, Yongping Huang

    In this study, we investigated the ability of κ ‐carrageenan to reinforce the heat‐induced EWP/Car gel system. A series of composite gels containing 0%–1.0% κ ‐carrageenan was prepared and characterized. The results showed that moderate κ ‐carrageenan addition (particularly 0.6%) significantly improved gel hardness, elasticity, and water‐holding capacity. Rheological and microstructural analyses confirmed that κ ‐carrageenan promoted the formation of a denser, more homogeneous network, as evidenced by lower tan δ values and uniform fluorescence and pore distribution in CLSM and SEM images. FTIR and SDS‐PAGE results indicated that these enhancements were mediated by noncovalent interactions without altering protein secondary structures. Moreover, the reduction in free sulfhydryl groups and increased disulfide bond formation revealed a strengthened protein matrix. These findings provide promising insights for the rational design and application of EWP‐based systems in the production and processing of egg‐based food products.


  • Open Access

    Epigallocatechin Gallate Inhibits Cell Proliferation Promoted by TNFα/IL1β‐NFκB‐PLAU Inflammatory Signaling in Esophageal Squamous Cell Carcinoma

    by Fei Zhou, Yuanduo Li, Yurui Zhang, Hui Zhu, Yun Li, Ying Nie, Junjun Sun, Qiulan Luo, Ruixuan Wang, Xianghui Zou, et al.

    Background: Proinflammatory cytokines TNFα and IL1β drive esophageal squamous cell carcinoma (ESCC) cell proliferation. However, the underlying molecular mechanism and potential therapeutic interventions to target this inflammatory signaling remain unclear. Methods: Plasminogen activator urokinase ( PLAU ) expression was analyzed using the public database (GEO and iProX) and molecular experiments (qRT‐PCR and Western blotting). The DNA‐binding activity of nuclear factor κB (NFκB) at the promoter of PLAU was analyzed using several online servers (AnimalTFDB, JASPAR, PROMO, Cistrome, and UCSC) and confirmed through ChIP‐qPCR. The role of PLAU in ESCC proliferation was investigated through PLAU overexpression experiments, GO annotation, CCK8 assay, and 5‐ethynyl‐2′‐deoxyuridine (EdU) incorporation assay. Results: PLAU expression was significantly higher in ESCC tissues compared to normal tissues and in ESCC cells compared to immortalized esophageal epithelial cells. Treatment with TNFα and IL1β induced NFκB binding at the PLAU promoter in ESCC cells, leading to increased PLAU expression. Conversely, treatment with BAY11‐7082, an NFκB inhibitor, significantly blocked this upregulation. Overexpression of PLAU promoted ESCC cell proliferation. Thus, our findings demonstrate that the TNFα/IL1β‐NFκB‐ PLAU axis promotes ESCC cell proliferation. Moreover, EGCG inhibited NFκB binding to the PLAU promoter, thereby preventing PLAU upregulation in TNFα/IL1β‐treated ESCC cells and inhibiting ESCC cell proliferation induced by PLAU overexpression. Conclusion: EGCG effectively blocks the inflammatory signaling TNFα/IL1β‐NFκB‐PLAU, thereby inhibiting ESCC cell proliferation. Our study provides new insights into blocking the pro‐proliferative role of inflammation in ESCC and highlights EGCG as a potential therapeutic agent.


  • Open Access

    The Regulative Effect and Mechanism in a MetS Mice Model of Functional Components in Freeze‐Dried Powder from Phyllanthus emblica L. Fruit

    by Yvping Wei, Yongping Huang, Yisheng Huang, Lei Hu, Xianghui Zou, Yaqun Liu, Qiulan Luo, Yuzhong Zheng, Fang Fang, Ying Nie

    The medicinal plant Phyllanthus emblica Linn. has been recognized for its health‐beneficial properties and has a long history of cultivation in ancient China and India. However, its effects and main mechanism in high‐fat diet (HFD)‐induced metabolic syndrome (MetS) have not been revealed yet. According to our findings, emblica fruit powder (EFP) through the freeze‐drying process was able to modulate the composition of the intestinal microbiota, with a significant increase in the beneficial bacteria genera Lactobacillus and Turicibacter. In addition, fecal metabolite profiling revealed that 20 metabolites were deferentially expressed, which were mainly organic acids, amino acids, and their derivatives. They are primarily enriched in the biological process of lipid metabolism, including the metabolism process of cholic acid, glycerophospholipid, and α‐linoleic acid. Subsequent qPCR testing of the liver tissue suggested that the regulatory effects of EFP in HFD mice may stem from its influence on the expression levels of over 20 key genes involved in host metabolic processes. In conclusion, EFP is able to alleviate the MetS caused by HFD, and this positive impact may be partially through the regulation of the “gut‐liver axis.” Consequently, EFP holds potential as a functional food ingredient for the prevention and management of MetS.

  • Open Access

    The Application of Raw Chickpeas and Nuts in the Development of Plant-Based Cheese Snack: Ideal Nutrition and Texture Properties

    by Ying Nie, Yaqun Liu, Qiulan Luo, Yisheng Huang, Lei Hu, Xianghui Zou, Yuzhong Zheng, Biansheng Li, Yongping Huang

    Human and global health would be greatly improved by replacing animal-based foods with plant-based alternatives. This transition would be facilitated when more affordable, convenient, sustainable, nutritious, and tasty plant-based foods are available on the market. Interest in related research has surged these years, and dozens of plant-based cheese (PBC) products have been introduced to the market. However, studies found that most PBCs are far from comparable with dairy cheese in nutritional value, and the texture and sensory properties are still hurdles to the widespread consumption of PBCs. This paper focused on the “tissue disruption route” and adopted chickpeas and nuts as the main ingredients to form a cheese snack. Test results showed that our samples were high of nourishment value compared to the cheese sample and even healthier than the cheese in the terms of energy ( vs. kJ/100 g, ), K/Na ratio (/ mg/100 g vs. / mg/100 g, ), DF ( g/100 g vs. N/A, ), and cholesterol ( vs. mg/100 g, ). From the order of magnitude, the PBC samples are similar to the cheese sample in the aspects of cohesiveness ( <svg...


  • Top Cited Papers
    Open Access

    Dietary Fiber: An Opportunity for a Global Control of Hyperlipidemia

    by Ying Nie, Feijun Luo

    Dietary fiber has a long history in the intervention study of hyperlipidemia. In this review, current understandings of structures, sources, and natures of various kinds of dietary fibers (DFs) were analyzed first. Available evidences for the use of different varieties of DFs in the lipid‐lowering action both in vitro and in vivo were subsequently classified, including both soluble ones, such as glucans, pectins, and gums, and insoluble ones, including arabinooxylans and chitosans, in order to draw a primary conclusion of their dose and molecular weight relationship with lipid‐lowering effect. Their potential mechanisms, especially the related molecular mechanism of protective action in the treatment and prevention of hyperlipidemia, were summarized at last. Five major mechanisms are believed to be responsible for the antihyperlipidemic benefits of DFs, including low levels of energy, bulking effect, viscosity, binding capacity, and fermentation thus ameliorating the symptoms of hyperlipidemia. From the molecular level, DFs could possibly affect the activities of HMG‐CoA reductase, LDL receptors, CYP7A1, and MAPK signaling pathway as well as other lipid metabolism‐related target genes. In summary, dietary fibers could be used as alternative supplements to exert certain lipid‐lowering effects on humans. However, more clinical evidence is needed to strengthen this proposal and its fully underlying mechanism still requires more investigation.